
51 - 200 funcionários
Fundada em 2019
🧬 Biotecnologia
💊 Farmacêutico
🔬 Ciência
💰 $85.000.000 Series B em 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics é uma empresa biofarmacêutica centrada no paciente e em estágio clínico, focada no desenvolvimento de terapias celulares para pacientes que sofrem de doenças autoimunes. A empresa está na vanguarda das terapias com células CAR T, aproveitando o poder transformador das células T para potencialmente proporcionar remissão sustentada e sem tratamento para condições autoimunes. O principal candidato a terapia com células CAR T da Kyverna, o KYV-101, está avançando em ensaios clínicos visando várias doenças autoimunes, incluindo esclerose múltipla, miastenia grave, esclerose sistêmica e nefrite lúpica. Seu pipeline apresenta terapias inovadoras com receptores de antígenos quiméricos (CAR) T-cells em formatos autólogos e alogênicos voltados para doenças autoimunes mediadas por células B.
🕒 Outubro 7
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $320.000 - $350.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
👻 Score fantasma 10%
🗣️🇺🇸🇬🇧 Inglês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

51 - 200 funcionários
Fundada em 2019
🧬 Biotecnologia
💊 Farmacêutico
🔬 Ciência
💰 $85.000.000 Series B em 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics é uma empresa biofarmacêutica centrada no paciente e em estágio clínico, focada no desenvolvimento de terapias celulares para pacientes que sofrem de doenças autoimunes. A empresa está na vanguarda das terapias com células CAR T, aproveitando o poder transformador das células T para potencialmente proporcionar remissão sustentada e sem tratamento para condições autoimunes. O principal candidato a terapia com células CAR T da Kyverna, o KYV-101, está avançando em ensaios clínicos visando várias doenças autoimunes, incluindo esclerose múltipla, miastenia grave, esclerose sistêmica e nefrite lúpica. Seu pipeline apresenta terapias inovadoras com receptores de antígenos quiméricos (CAR) T-cells em formatos autólogos e alogênicos voltados para doenças autoimunes mediadas por células B.
• Own the commercial marketing strategy for the company’s CAR-T portfolio across current and future autoimmune indications • Develop and lead the overall marketing strategy and commercial vision • Establish strategic capabilities, infrastructure, and organizational readiness • Define launch objectives, customer priorities, brand positioning, messaging, channel strategy, unbranded education, promotional approach, and measurement • Translate clinical data, market research, competitive intelligence, and customer insights into actionable marketing strategies • Develop understanding of patient journeys, referral ecosystems, treatment pathways, and adoption barriers across autoimmune diseases • Lead the marketing organization through the company’s first product launch and establish a repeatable launch model • Establish launch performance metrics and optimize strategy using market feedback, customer behavior, competitive activity, and emerging data • Develop post-launch strategies and differentiated lifecycle strategies for additional indications, patient populations, and disease settings • Partner with Clinical Development, Medical Affairs, Market Access, Commercial Operations, Sales, Regulatory, and Legal/Compliance • Establish customer and market insights capabilities • Provide commercial perspectives to senior leadership and the executive team • Build and lead a high-performing marketing organization • Determine required capabilities, talent, agency partnerships, and infrastructure • Establish objectives, operating processes, and performance metrics • Develop a culture of accountability, strategic thinking, collaboration, and agile execution
• 15+ years of progressive experience in biopharmaceutical commercial/marketing roles • Significant experience in specialty, rare disease, hematology, immunology, or other complex therapeutic markets • Demonstrated experience personally leading a successful U.S. product launch from pre-launch through commercialization • Experience developing commercialization strategies for innovative therapies, preferably CAR-T, cell therapy, gene therapy, or other highly specialized treatments • Proven experience developing multi-indication and lifecycle strategies for a pharmaceutical or biotechnology asset • Experience building or significantly transforming a marketing organization in a growth-stage or emerging biotech environment • Strong understanding of commercialization, brand strategy, market development, customer segmentation, personal and digital engagement, market research, forecasting, and promotional strategy • Ability to translate complex clinical/scientific data into differentiated commercial positioning • Experience working across Medical Affairs, Clinical Development, Market Access, Regulatory, Sales, and executive leadership • Understanding of treatment, referral, reimbursement, and healthcare-provider ecosystems associated with specialty and cell therapies • Understanding of challenges associated with launching innovative or highly specialized therapies • Exceptional strategic thinking and willingness to personally drive execution • Exceptional communication and executive presence • Ability to influence senior leadership and cross-functional stakeholders • Ability to operate effectively in a fast-paced, entrepreneurial environment with evolving priorities
• Bonus eligibility • Benefits • Participation in Company’s stock plan • Remote work arrangement • Approximately 25–40% travel
Candidatar-se🕒 Outubro 7
Vice President leading pricing, reimbursement, payer engagement, and commercialization access for SpyGlass Pharma’s ophthalmic drug-delivery therapies. Building the market access organization for Phase 3 and launch growth.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $325.000 - $385.000 / ano
💰 $75.000.000 Series D - Spyglass Pharma em 2025-06
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Outubro 6
Regional Vice President driving annuity production and wholesaling for Protective, an insurance provider. Managing advisor relationships and sales across North Carolina and East Tennessee.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $60.750 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Outubro 6
Regional Vice President selling qualified retirement plans to Central Valley, California small and mid-sized markets. Building intermediary networks, managing prospects, and traveling extensively across the assigned territory.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $90.000 - $100.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Outubro 6
Divisional Vice President leading regional sales professionals wholesaling qualified retirement plans for Transamerica. Managing growth, recruiting talent, coaching RVPs, and driving intermediary-channel sales.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $200.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Outubro 6
Regional Vice President selling qualified retirement plans through financial intermediaries. Managing U.S. territories, advisor networks, prospects, and retirement-market sales goals for Transamerica.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $90.000 - $100.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório